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 Methacrylate-based monolithic reactors with immobilized PNGase F were prepared in 
capillary format. 
 Oriented and non-oriented immobilization procedures were compared. 
 The prepared PNGase F reactors were used for deglycosylation of glycoproteins followed 
by CE/LIF and/or MALDI/MS analysis. 
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Abstract 27 
In this paper we report on a novel oriented peptide-N-glycosidase F (PNGase F) 28 
immobilization approach onto methacrylate based monolithic support for rapid, reproducible 29 
and efficient release of the N-linked carbohydrate moieties from glycoproteins. The 30 
glutathione-S-transferase-fusion PNGase F (PNGase F-GST) was expressed in E. coli using 31 
regular vector technology. The monolithic pore surface was functionalized with glutathione 32 
via a succinimidyl-6-(iodoacetyl-amino)-hexanoate linker and the specific affinity of GST 33 
towards glutathione was utilized for the oriented coupling. This novel immobilization 34 
procedure was compared with reductive amination technique commonly used for non-35 
oriented enzyme immobilization via primary amine functionalities. Both coupling approaches 36 
were compared using enzymatic treatment of several glycoproteins, such as ribonuclease B, 37 
fetuin and immunoglobulin G followed by MALDI/MS and CE-LIF analysis of the released 38 
glycans. Orientedly immobilized PNGase F via GST-glutathione coupling showed 39 
significantly higher activity, remained stable for several months, and allowed rapid release of 40 
various types of glycans (high-mannose, core fucosylated, sialylated, etc.) from 41 
glycoproteins. Complete protein deglycosylation was obtained as fast as in several seconds 42 
when using flow-through immobilized microreactors. 43 
 44 
 45 
Keywords: enzyme microreactor, oriented immobilization, monolith, PNGase F, 46 
deglycosylation. 47 
 48 
Abbreviations: AIBN, 2,2´-azobisisobutyronitrile, APTS, 8-aminopyrene-1,3,6-trisulphonic 49 
acid; EDMA, ethylene dimethacrylate; GMA, glycidyl methacrylate; GSH, glutathione; GST, 50 
glutathione-S-transferase; PNGase F, peptide-N-glycosidase F.  51 
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1 Introduction 52 
Microreactors are becoming important tools in many research and development areas ranging 53 
from organic synthesis [1] to diesel fuel production [2,3]. Immobilized enzyme reactors are 54 
under rapid recent development, especially for bioanalytical purposes related to the omics 55 
fields. Besides the most common immobilized trypsin reactors [4,5] other enzymes, 56 
including, e.g., the endoproteinase LysC have been also successfully used [6]. While many 57 
different forms of solid support can be used for enzyme immobilization, including 58 
chromatographic particles [7], self-assembled magnetic beads [8] or open fused silica 59 
capillary surfaces [9], porous monoliths represent a promising choice due to their excellent 60 
mechanical and chemical properties, which can be easily fine-tuned for a plethora of special  61 
applications [10]. 62 
Enzymatic release of glycans from glycoproteins represents a key step in analytical 63 
glycomics. Peptide-N-glycosidase F (PNGase F) is one of the most frequently used 64 
endoglycosidases utilized to release N-linked glycans. The common in-solution 65 
deglycosylation method is a relatively time-consuming process requiring several hours up to 66 
overnight for complete removal of all N-linked glycans. While it has been shown that the 67 
deglycosylation time can be reduced to minutes by microwave irradiation [11,12] or pressure-68 
cycling [13], the simplest way to speed up the reaction is increasing the enzyme to substrate 69 
ratio by immobilization of PNGase F on a solid support. Both particulate and monolithic 70 
supports were used for PNGase F immobilization via non-specific coupling chemistries 71 
including CNBr-activated Sepharose 4B [14], glycidoxypropyltrimethoxysilane modified 72 
silica beads [15], carboxylated nanodiamonds [16], or acrylic polymer particles containing 73 
amine functionalities [17]. Solid supports with immobilized PNGase F can be suspended in 74 
the glycoprotein solution [16], packed into a column [14], capillary [17] or microfluidic chip 75 
[15] in order to create flow-through reactors. Monolithic PNGase F reactors prepared in 76 
capillary format were reported earlier [18-20] as promising alternatives to packed column 77 
reactors. Palm and Novotny immobilized PNGase F on the surface of polyacrylamide based 78 
monoliths via succinimide functionalities [18]. Immobilization of PNGase F on monolithic 79 
support via azlactone chemistry [19] or reductive amination [20] was just recently published. 80 
Currently, all coupling methods employ non-specific reactions between the primary 81 
amines of PNGase F with reactive functionalities generated on a solid support surface. Since 82 
amino groups are also present at the active site of the enzyme molecule, the resulting non-83 
oriented immobilization may negatively affect accessibility of the active site leading to 84 
reduced activity of the immobilized enzyme. It can be expected that enzyme immobilization 85 
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through a selected functional group instead of randomly reacting amines will result in 86 
predictable, and therefore better performing microreactors. 87 
With the use of recombinant DNA technology a wide variety of proteins, including 88 
enzymes, can be produced with specific sequences allowing site selective binding. Such 89 
fusion systems were developed for purification of recombinant proteins from cell lysates 90 
through affinity capture. While the tags are usually removed from the protein molecules 91 
before further use, they offer a special advantage as specific moieties for oriented 92 
immobilization. In particular, a discrete modification using a highly specific tag attached to 93 
the enzyme molecule during its synthesis can be employed for direct coupling reactions away 94 
from the active center of the enzyme molecule. 95 
In this work we report on a novel oriented PNGase F immobilization method onto a 96 
methacrylate based monolithic support prepared in a 250 m ID fused silica capillary for 97 
rapid and efficient N-glycan removal from glycoproteins. Our approach is based on the 98 
affinity of glutathione (GSH) immobilized on the monolithic surface towards glutathione-S-99 
transferase fusion PNGase F (PNGase F-GST). The developed oriented immobilization was 100 
compared with the non-oriented approach in enzymatic treatments of several standard 101 
glycoproteins including ribonuclease B, fetuin and immunoglobulin G, followed by off-line 102 
MALDI/MS and CE-LIF analysis of released glycans. 103 
 104 
2 Experimental part 105 
2.1 Materials and reagents 106 
Glycidyl methacrylate (GMA), ethylene dimethacrylate (EDMA), 1-dodecanol, 107 
cyclohexanol, 2,2´-azobisisobutyronitrile (AIBN), 3-(trimethoxysilyl)propyl methacrylate, 108 
sodium periodate, sodium cyanoborohydride, chloroform, iodomethane, dithiotreitol, and 109 
iodoacetamide were purchased from Sigma-Aldrich (Prague, Czech Republic). GMA and 110 
EDMA were purified by passing them through a column containing basic alumina inhibitor 111 
remover (Sigma-Aldrich). Succinimidyl-6-[(iodoacetyl)amino]hexanoate was purchased from 112 
Chem-Impex International (Wood Dale, IL). 8-aminopyrene-1,3,6-trisulphonic acid (APTS) 113 
was purchased from Beckman Coulter (Brea, CA). 114 
PNGase F-GST was expressed in E. coli using regular vector technology and purified 115 
by affinity chromatography [21,22]. The expression of PNGase F-GST was confirmed by 116 
SDS-PAGE of cell lysates followed by Coomassie Brilliant Blue R-250 staining. 117 
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Polyclonal human immunoglobulin G (hIgG), bovine ribonuclease B (RNase B), 118 
bovine fetuin, PNGase F, glutathione, super-dihydroxybenzoic acid (9:1 mixture of 119 
dihydroxybenzoic acid and 2-hydroxy-5-methoxybenzoic acid) and sinapinic acid were 120 
purchased from Sigma-Aldrich. 121 
Polyimide-coated fused-silica capillary (250 µm ID, 375 µm OD) was purchased from 122 
Polymicro Technologies (Phoenix, AZ). 123 
 124 
2.2 Instrumentation 125 
MALDI/MS measurements were carried out using an AB SCIEX TOF/TOF 5800 system 126 
(Framingham, MA, USA). CE-LIF separations were performed on a P/ACE MDQ instrument 127 
(Beckman Coulter) equipped with an Ar-ion laser (488 nm excitation wavelength) for 128 
fluorescent detection. 129 
The elemental composition of monolithic columns was determined by scanning 130 
electron microscopy with energy dispersive X-ray analysis (SEM/EDAX) on a JEOL JSM-131 
5500 LV instrument equipped with an analyzer IXRF Systems and a detector Gresham Sirius 132 
10. 133 
 134 
2.3 Preparation of monolithic poly(glycidyl methacrylate-co-ethylene 135 
dimethacrylate) support 136 
The inner surface of the fused silica capillary was first activated with 3-137 
(trimethoxysilyl)propyl methacrylate [23]. The polymerization mixture consisting of 25.5% 138 
GMA, 17.5% EDMA, 40% 1-dodecanol, 17% cyclohexanol, and 1% AIBN (with respect to 139 
monomers) (all percentages w/w) was purged with nitrogen for 10 min. The vinylized 140 
capillary was filled with this mixture and thermally initiated polymerization was carried out 141 
in a water bath at 60 C for 24 h. After polymerization, the porogenic solvents were removed 142 
from the monolith by pumping acetonitrile through the column at a flow rate of 60 µL/h for 1 143 
h. 144 
 145 
2.4 Oriented immobilization of PNGase F-GST 146 
The poly(GMA-co-EDMA) monolithic column was filled with a 30% (v/v) solution of 147 
ammonium hydroxide, sealed with silicone septa and heated in a column oven to 70 C for 3 148 
h. The modified column was washed with water (150 µL/h, 1 h) and dimethyl sulfoxide 149 
(DMSO) (150 µL/h, 15 min). The resulting primary amine functionalized monolithic column 150 
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was flushed with a solution of succinimidyl-6-[(iodoacetyl)amino]hexanoate in DMSO (10 151 
mg/mL) at a flow rate of 150 µL/h for 3 h in dark at room temperature. Next, a solution of 152 
glutathione (10 mg/mL) in 20 mmol/L Tris-HCl buffer, pH 8.3 was pumped through the 153 
iodoacetate functionalized column at a flow rate of 150 µL/h for 3 h in dark at room 154 
temperature. The scheme of the activation procedure is in Figure 1. The glutathione modified 155 
column was washed with the 20 mmol/L Tris-HCl buffer, pH 8.3. PNGase F-GST (1 mg/mL) 156 
was dissolved in 10 mmol/L phosphate buffered saline (PBS). The enzyme solution was 157 
pumped through the glutathione modified monolithic column at room temperature for 2.5 h 158 
with a flow rate of 100 µL/h. The PNGase F-GST conjugated monolith was then washed with 159 
10 mmol/L PBS (100 µL/h, 1 h) and stored at 4 °C before further use. 160 
 161 
2.5 Non-oriented immobilization of PNGase F-GST 162 
The poly(GMA-co-EDMA) monolithic column was filled with 0.5 mol/L sulfuric acid, sealed 163 
with silicone septa and heated in a column oven to 70 C for 3 h. The monolithic column was 164 
washed with water (150 µL/h, 1 h) followed by rinsing with a freshly prepared solution of 0.1 165 
mol/L sodium periodate (150 µL/h, 1.5 h). PNGase F-GST (1 mg/mL) was dissolved in 10 166 
mmol/L PBS, containing 3 mg/mL sodium cyanoborohydride. The enzyme solution was 167 
pumped through the aldehyde functionality modified monolith at room temperature for 2.5 h 168 
with a flow rate of 100 µL/h. The monolith conjugated with PNGase F-GST was then washed 169 
with 10 mmol/L PBS (100 µL/h, 1 h) and stored at 4 C before further use. 170 
 171 
2.6 Sample preparation 172 
Stock solutions (5 mg/mL) of ribonuclease B, fetuin and hIgG were prepared in 5 mmol/L 173 
sodium bicarbonate, pH 8.0 containing 10 % acetonitrile. Ribonuclease B and fetuin were 174 
denaturated before deglycosylation by the addition of dithiotreitol to the glycoprotein 175 
solution in a final concentration of 5 mmol/L and incubation at 65 °C for 15 min. Next, 176 
iodoacetamide was added in a final concentration of 5 mmol/L and the solution was 177 
incubated in dark at room temperature for 15 min. Before deglycosylation, the glycoprotein 178 
solutions were diluted by 5 mmol/L sodium bicarbonate, pH 8.0, containing 10 % 179 
acetonitrile. 180 
 181 
2.7 Release of N-glycans using immobilized PNGase F-GST 182 
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Deglycosylation using immobilized PNGase F-GST was carried out at room temperature for 183 
1-6 min. The glycoprotein solutions (1.0-2.5 mg/mL) were pumped through the monolithic 184 
reactors (2.5-10 cm) at different flow rates by means of a syringe pump. The released glycans 185 
were collected in microvials and stored at 4 °C before further analysis. 186 
 187 
2.8 Release of glycans using soluble PNGase F and PNGase F-GST 188 
Deglycosylation of denaturated ribonuclease B (50 g) was performed using soluble PNGase 189 
F-GST and commercially available PNGase F (Sigma Aldrich). The enzyme was added to the 190 
protein solution in a concentration of 0.1 nmol/L and deglycosylation was carried out at 37 191 
°C for 2 h. The released glycans were collected in microvials and stored at 4 °C before 192 
further analysis. 193 
 194 
2.9 Labeling and purification of the released glycans 195 
The deglycosylated proteins were removed from the collected fractions (50 L) using 10 kDa 196 
MWCO centrifugal filter units (Millipore, Billerica, MA) before the glycan labeling step. The 197 
glycan-containing supernatants were dried in a SpeedVac concentrator and labeled via 198 
reductive amination by the addition of 2 μL of 50 mmol/L APTS in 15% acetic acid and 4 μL 199 
of 1 mol/L sodium cyanoborohydride in tetrahydrofuran. The labeling reaction was 200 
performed at 37 °C overnight. Labeled glycans were purified using cleanup cartridges 201 
(Prozyme, Hayward, CA) following the protocol suggested by the manufacturer. The APTS 202 
labeled glycan solutions were collected in microvials, dried in a SpeedVac concentrator and 203 
redissolved in water (50 L) before CE-LIF analysis. 204 
 205 
2.10 CE-LIF analysis of the labeled glycans 206 
CE-LIF separations of APTS labeled glycans were performed on a Beckman P/ACE MDQ 207 
instrument using a neutral coated N-CHO (PVA) capillary (Beckman Coulter, 50 m ID/365 208 
m OD, 60-cm total length, 50-cm effective length) and a commercially available 209 
carbohydrate separation gel buffer (Beckman Coulter) as a background electrolyte. The 210 
instrument was equipped with a 488 nm laser module and a 520 nm cut-off filter for LIF 211 
detection. Samples were injected by pressure at 6.9 kPa (1 psi) for 5 s. The capillary was 212 
rinsed with the separation buffer between injections for 5 min at 206.8 kPa (30 psi) in order 213 
to avoid any sample carryover. All separations were performed at 25 °C by applying −30 kV 214 
separation voltage (E = 500 V/cm). 215 
8 
 
 216 
2.11 Permethylation 217 
Permethylation of N-linked glycans released from fetuin was performed according to the 218 
published procedure in [24]. Briefly, spin columns were packed with sodium hydroxide beads 219 
(20-40 mesh) washed with DMSO and spun down at 1000 rpm for 2 min. Before 220 
permenthylation, proteins were removed from the collected fractions (50 L) using 10 kDa 221 
MWCO centrifugal filters, dried in a SpeedVac concentrator and redissolved in a solution 222 
containing 140 L DMSO, 54 L iodomethane and 6 L water. Next, the sample was passed 223 
through the spin column at 1000 rpm for 2 min. The process was repeated 10 times. The 224 
permethylated glycans were extracted with chloroform and washed repeatedly with water. 225 
The extracts were dried in a SpeedVac concentrator and redissolved in a solution (50 L) 226 
containing 50 % methanol and 50 % 5 mmol/L sodium bicarbonate. 227 
 228 
2.12 MALDI/MS analysis of proteins and released glycans 229 
Before MALDI/MS analysis of proteins, the collected fractions were 10 times diluted by 230 
water and mixed with a sinapinic acid solution (10 mg/mL, prepared in 50% acetonitrile 231 
containing 0.1% trifluoroacetic acid) in a 1:1 (v/v) ratio. Proteins were analyzed in the 232 
positive linear ion mode. The released glycans (native or permethylated) were analyzed by 233 
MALDI/MS without any dilution/pre-concentration steps. The samples were mixed with 234 
super-dihydroxybenzoic acid solution (20 mg/mL, prepared in water) in 1:1 (v/v) ratio and 235 
analyzed in the positive reflectron ion mode. 236 
 237 
3 Results and discussion 238 
In this work we describe a novel oriented immobilization technique of PNGase F on 239 
monolithic support. Prior to immobilization the activity of the expressed and purified PNGase 240 
F-GST was tested by in-solution deglycosylation of bovine ribonuclease B (RNase B). RNase 241 
B is a relatively small glycoprotein containing four disulfide bonds and a single glycosylation 242 
site at Asn34, where five to nine mannose residues can be attached to the chitobiose core. The 243 
released glycans were APTS labeled and analyzed by CE-LIF. Figure 1 2 shows the 244 
electrophoretic profile of the APTS-labeled glycans released from RNase B, confirming 245 
efficient expression and good isolation of the active PNGase F-GST. Table 1 delineates the 246 
glycan structures and GUCE values for all significant peaks corresponding to APTS-labeled 247 
RNase B glycans detected by CE-LIF. 248 
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We have compared the in solution digestion activity of the PNGase F-GST conjugate 249 
to that of the commercially available PNGase F (Sigma Aldrich) under the same conditions. 250 
The obtained electropherograms of APTS-labeled glycans released from ribonuclease B did 251 
not show any difference between the enzyme treatments. Furthermore, the samples treated 252 
using soluble enzymes were also analyzed by SDS-PAGE. The complete deglycosylation of 253 
ribonuclease B was observed after treatment by both enzymes, confirming that PNGase F-254 
GST has similar activity as the commercially available counterpart. 255 
 256 
3.1 Immobilization of PNGase F-GST 257 
The oriented approach required modification of the monolithic pore surface by immobilized 258 
GSH. Therefore, the poly(GMA-co-EDMA) monolith prepared by thermally initiated radical 259 
polymerization in a 250 µm ID fused silica capillary was activated via a multistep procedure 260 
shown in Figure 2 (Figure 1). The monolith was first treated with an aqueous ammonia 261 
solution and then functionalized with succinyl-6-[(iodoacetyl)amino]hexanoate to assure the 262 
oriented coupling of GSH to the monolith. Iodoacetyl groups react specifically and efficiently 263 
with sulfhydryl functionalities forming covalent thioether bonds, permanently attaching GSH 264 
to the monolithic column. Each step of the monolith modification was characterized by 265 
fluorescent microscopy as well as SEM/EDAX analysis. The specific reaction of 266 
fluorescamine with primary amines forming a highly fluorescent product was employed for 267 
qualitative characterization of the efficient amination of the monolith as well as the 268 
immobilization of GSH via sulfhydryl functionalities. Furthermore, the SEM/EDAX analysis 269 
confirmed the presence of iodine (1.54 wt%) and sulfur (0.15 wt%) in the iodoacetyl- and 270 
GSH-modified monolithic columns. In the last step, a solution of PNGase F-GST was flushed 271 
through the GSH-modified column resulting in the required oriented immobilization of 272 
PNGase F via the GST tag. 273 
 274 
3.2 Optimization of the PNGase F-GST reactor performance 275 
RNase B was used as a model glycoprotein for digestion condition optimization. It has been 276 
shown that globular glycoproteins with several disulfide bridges are often resistant to PNGase 277 
F cleavage requiring a denaturation step to increase deglycosylation efficiency [18,19]. 278 
Therefore, the effect of RNase B denaturation was studied in our initial experiments. Since 279 
MALDI/MS was chosen for the analysis of the native glycans released from RNase B, 280 
enabling rapid generation of the desired information, no detergents were used for protein 281 
denaturation. RNase B was only reduced by dithiotreitol before endoglycosidase treatment 282 
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using a monolithic reactor containing PNGase F-GST prepared by oriented immobilization. 283 
Solutions of native or denatured RNase B (1 mg/mL) were flushed through the 10 cm long 284 
reactor at room temperature setting the respective residence times for 1 min. The eluents were 285 
collected and analyzed by MALDI/MS. The resulting neutral glycans exhibited low 286 
ionization efficiency; therefore, another deglycosylation step was performed in 5 mmol/L 287 
sodium bicarbonate solution, pH 8.0 containing 10% (v/v) acetonitrile and the released 288 
glycans were detected as sodium cationized molecular species. The glycan structures and 289 
mass values for peaks corresponding to the RNase B glycans are summarized in Table 1. The 290 
initial experiments attempting deglycosylation of native RNase B using the immobilized 291 
PNGase F-GST reactor were unsuccessful and only low signal peaks were found in the 292 
MALDI/MS spectrum that corresponded to the released glycans (Figure 3a). It was also 293 
confirmed by MALDI/MS analysis in the linear mode, where the peaks corresponding to 294 
glycosylated protein (m/z~15.3 kDa) dominated the mass spectrum (Figure 3b). In contrast, 295 
denaturation of RNase B prior to enzymatic treatment significantly improved deglycosylation 296 
efficiency. The peaks corresponding to the intact or partially deglycosylated RNase B 297 
disappeared and only peaks corresponding to the completely deglycosylated protein were 298 
found in the mass spectrum (Figure 3d). The signal intensities of peaks corresponding to 299 
released glycans increased as shown in Figure 3c. 300 
 301 
3.3 Effect of the immobilization technique on reactor efficiency 302 
The oriented immobilization via the GST tag was compared with the non-oriented reductive 303 
amination technique introduced in the monolithic area by Petro et al. [25], which was based 304 
on the reaction of the primary amines of PNGase F-GST with aldehyde functionalities 305 
generated on the monolithic surface.  306 
In order to see the difference in the efficiency of both reactors, very short 307 
deglycosylation times of 30 seconds were used for the RNase B treatment. A solution of 308 
denaturated RNase B (2.5 mg/mL) was flushed through 2.5 cm long monolithic reactors at 309 
room temperature and the collected fractions were analyzed by MALDI/MS in linear mode as 310 
shown in Figure 4. Only partial deglycosylation of RNase B was obtained by the PNGase F-311 
GST reactor prepared by non-oriented immobilization as shown in the MALDI spectrum 312 
containing the peaks of original glycosylated protein (m/z ~6.7 kDa and ~15.3 kDa) (Figure 313 
4a). In contrast to non-oriented PNGase F-GST immobilization, the oriented immobilization 314 
technique provided an efficient monolithic reactor as demonstrated by complete RNase B 315 
deglycosylation (Figure 4b). 316 
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It has been shown that the immobilization chemistry can affect the density of 317 
immobilized enzyme and consequently the performance of the enzyme reactor. For example, 318 
trypsin immobilization via azlactone functionalities can improve the reactor performance in 319 
comparison to the widely used coupling via epoxy groups [6]. However, both procedures lead 320 
to non-oriented immobilization of enzyme, which can negatively affect accessibility of the 321 
active site and reduce activity of the immobilized enzyme. 322 
In the next experiments, bovine fetuin was used to examine the performance of the 323 
immobilized PNGase F-GST monolithic reactors. Bovine fetuin is an acidic glycoprotein 324 
containing four O-linked (Ser253, Thr262, Ser264, Ser323) and three N-linked (Asn81, 325 
Asn138, Asn158) glycosylation sites, with heavily sialylated glycans attached. A solution of 326 
denatured bovine fetuin (1 mg/mL) was flushed through 10 cm long monolithic reactors at a 327 
flow rate to maintain the deglycosylation time of 1 min. The direct comparison of 328 
deglycosylation performance of both types of reactors i.e., with oriented and non-oriented 329 
immobilization is shown in Figure 5. With non-oriented enzyme immobilization the main 330 
product peaks of ~20.8 kDa and ~41.5 kDa represent the molecular masses of the doubly and 331 
singly charged partially deglycosylated protein (Figure 5b). On the other hand, the 332 
MALDI/MS analysis of fetuin treated by the reactor prepared by oriented immobilization of 333 
PNGase F-GST provided the mass spectrum containing the main peaks of ~19.6 kDa and ~39 334 
kDa corresponding to the molecular masses of the doubly and singly charged bovine fetuin 335 
after complete release of N-linked glycans (Figure 5c). The fetuin glycans released by 336 
immobilized PNGase F-GST (oriented immobilization) were also detected by MALDI/MS 337 
(Figure 6); however, due to the low stability of sialic acid residues in acidic glycans the 338 
permethylation step was performed prior to mass spectrometry analysis. The glycan 339 
structures and mass values for all significant peaks corresponding to the permethylated 340 
sodium cationized fetuin glycans are summarized in Table 2. 341 
The MS spectra shown in Figures 4 and 5 clearly indicate the significant efficiency 342 
difference between the monolithic PNGase F-GST reactors prepared by non-oriented (Figures 343 
4a and 5b) and oriented (Figures 4b and 5c) immobilization techniques. Since the same 344 
monolith and the same enzyme was used for preparation of both reactors, the main reason for 345 
this difference can be attributed to the immobilization techniques where the oriented PNGase 346 
F molecules provided higher density with more accessible active sites. 347 
It should be emphasized that both types of reactors, i.e., with oriented and non-348 
oriented immobilization were very stable. The reactors were used repeatedly within a period 349 
of five months, washed with buffer and stored in refrigerator between experiments. No 350 
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apparent decrease in activity of immobilized PNGase F-GST was observed in comparison to 351 
the initial experiments as demonstrated by complete deglycosylation of RNase B (2.5 352 
mg/mL) in 15 seconds using the repeatedly used monolithic reactor. 353 
 354 
3.4 Deglycosylation of human immunoglobulin G 355 
In order to demonstrate the deglycosylation performance of the immobilized PNGase F-GST 356 
reactor with larger proteins, analysis of polyclonal human immunoglobulin G (hIgG) was 357 
performed. IgG contains a single conserved N-glycosylation site at Asn297 on both heavy 358 
chains in the CH2 domain of the Fc region. Since the denaturation process resulted in 359 
precipitation of hIgG, deglycosylation was carried out without denaturation. A solution of 360 
native hIgG was pumped through the monolithic PNGase F-GST reactor prepared by oriented 361 
immobilization at a flow rate maintaining 3 min residence time. Figure 7 shows the capillary 362 
electrophoretic profile of the APTS-labeled glycans released from hIgG. The structures and 363 
GUCE values for all significant peaks corresponding to APTS-labeled glycans detected by 364 
CE-LIF are summarized in Table 3. The native glycans released from hIgG were also 365 
detected by MALDI/MS, but the losses of sialic acid residues from released glycans were 366 
often observed. However, this can be minimized by glycan permethylation prior to the MS 367 
analysis as demonstrated above during the analysis of acidic fetuin glycans. The obtained 368 
data clearly demonstrate the efficient release of all respective glycans from hIgG using the 369 
immobilized PNGase F-GST monolithic reactor. 370 
 371 
4 Conclusions 372 
In summary, the described oriented immobilization of PNGase F on porous monolithic 373 
support significantly increased the efficiency of the flow through microreactor. Complete 374 
protein deglycosylation could be obtained in seconds with oriented or minutes with non-375 
oriented immobilized reactors, compared to several hours when in-solution digestion is used. 376 
The key component for achieving the highest processing speed was with permeable 377 
monolithic support and oriented immobilization of the enzyme allowing complete 378 
deglycosylation of RNase B (2.5 mg/mL) in 15 seconds using a 25 mm long, 250 m id 379 
microreactor. Such a processing speed can significantly shorten the glycoprotein analysis 380 
workflow from several hours to several minutes or even less in comparison to traditional in-381 
solution glycoprotein treatment. Furthermore, the immobilized PNGase F reactor enables the 382 
integration of glycoprotein deglycosylation into multidimensional capillary [19,20] or 383 
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microfluidic [15] based platforms incorporating glycoprotein digestion, protein removal, 384 
glycan capture and separation followed by MS analysis and open up new automated protocol 385 
without any manual interference for a broad range of glycoprotein analysis. 386 
 387 
Acknowledgement 388 
The Project was partially funded by the SoMoPro programme. Research leading to these 389 
results has received financial contribution from the European Community within the Seventh 390 
Framework Programme (FP/2007-2013) under Grant Agreement No. 229603. The research 391 
was also co-financed by the South Moravian Region. Additional financial support from the 392 
Grant Agency of the Czech Republic (P206/12/G014P301/11/2055), the Academy of 393 
Sciences of the Czech Republic (M200311201) and the institutional research plan (RVO: 394 
68081715) is also acknowledged. This work was also supported by the Fulbright Research 395 
Scholarship (I-174444), the OTKA Grant of the Hungarian Research Council (K-81839) and 396 
the MTA-PE Translational Glycomics program (97101) of the Hungarian Academy of 397 
Sciences. Part of the work was realized in CEITEC - Central European Institute of 398 
Technology with research infrastructure supported by the project CZ.1.05/1.1.00/02.0068 399 
financed from European Regional Development Fund. 400 
 401 
References 402 
[1] P. Watts, S. J. Haswell, Chem. Soc. Rev. 34 (2005) 235. 403 
[2] Y. Asanomi, H. Yamaguchi, M. Miyazaki, H. Maeda, Molecules 16 (2011) 6041. 404 
[3] J. Urban, F. Svec, J.M.J. Frechet, Biotechnol. Bioeng. 109 (2012) 371. 405 
[4] J. Krenkova, F. Foret, Electrophoresis 25 (2004) 3550. 406 
[5] J. Krenkova, Z. Bilkova, F. Foret, J. Sep. Sci. 28 (2005) 1675. 407 
[6] J. Krenkova, N.A. Lacher, F. Svec, Anal. Chem. 81 (2009) 2004. 408 
[7] R.A. Sheldon, Adv. Synth. Catal. 349 (2007) 1289. 409 
[8] A. Le Nel, J. Krenkova, K. Kleparnik, C. Smadja, M. Taverna, J.L. Viovy, F. Foret, 410 
Electrophoresis 29 (2008) 4944. 411 
[9] J. Krenkova, K. Kleparnik, F. Foret, J. Chromatogr. A 1159 (2007) 110. 412 
[10] F. Svec, J. Chromatogr. A 1217 (2010) 902. 413 
[11] W.N. Sandoval, F. Arellano, D. Arnott, H. Raab, R. Vandlen, J.R. Lill, Int. J. Mass 414 
Spectrom. 259 (2007) 117. 415 
[12] H. Zhou, A.C. Briscoe, J.W. Froehlich, R.S. Lee, Anal. Biochem. 427 (2012) 33. 416 
[13] Z. Szabo, A. Guttman, B.L. Karger, Anal. Chem. 82 (2010) 2588. 417 
14 
 
[14] J.B.L. Damm, J.P. Kamerling, G.W.K. Vandedem, J.F.G. Vliegenthart, Glycoconjugate 418 
J. 4 (1987) 129. 419 
[15] M.A. Bynum, H.F. Yin, K. Felts, Y.M. Lee, C.R. Monell, K. Killeen, Anal. Chem. 81 420 
(2009) 8818. 421 
[16] L.M. Wei, W. Zhang, H.J. Lu, P.Y. Yang, Talanta 80 (2010) 1298. 422 
[17] Y.Y. Qu, S.M. Xia, H.M. Yuan, Q. Wu, M. Li, L.J. Zou, L.H. Zhang, Z. Liang, Y.K. 423 
Zhang, Anal. Chem. 83 (2011) 7457. 424 
[18] A.K. Palm, M.V. Novotny, Rapid Commun. Mass Spectrom. 19 (2005) 1730. 425 
[19] J. Krenkova, N.A. Lacher, F. Svec, J. Chromatogr. A 1216 (2009) 3252. 426 
[20] Y. Jmeian, L.A. Hammad, Y. Mechref, Anal. Chem. 84 (2012) 8790. 427 
[21] G.D. Barsomian, T.L. Johnson, M. Borowski, J. Denman, J.F. Ollington, S. Hiani, D.S. 428 
McNeilly, J.R. Rasmussen, J. Biol. Chem. 265 (1990) 6967. 429 
[22] A.L. Tarentino, G. Quinones, A. Trumble, L.-M. Changchien, B. Duceman, F. Maley, 430 
T.H. Plummer, J. Biol. Chem. 265 (1990) 6961. 431 
[23] J. Krenkova, A. Gargano, N.A. Lacher, J.M. Schneiderheinze, F. Svec, J. Chromatogr. A 432 
(2009) 6824. 433 
[24] P. Kang, Y. Mechref, I. Klouckova, M.V. Novotny, Rapid Commun. Mass Spectrom. 19 434 
(2005) 3421. 435 
[25] M. Petro, F. Svec, J.M.J. Frechet, Biotechnol. Bioeng. 49 (1996) 355.  436 
15 
 
Figure captions 437 
 438 
Figure 12. Scheme of monolith modification by glutathione. 1 - succinimidyl-6-439 
[(iodoacetyl)amino]hexanoate, 2 – glutathione. 440 
 441 
Figure 12. Capillary electrophoresis profile of the APTS-labeled glycans released from 442 
RNase B using in solution PNGase F-GST digestion. 443 
 444 
Figure 3. MALDI/MS spectra of bovine RNase B (b, d) and glycans (a, c) released by 445 
immobilized PNGase F-GST reactor: (a, b) native RNase B, (c, d) denaturated RNase B. 446 
Protein concentration: 1.0 mg/mL, deglycosylation time: 1 min. The individual detected 447 
glycans are listed in Table 1. 448 
 449 
Figure 4. MALDI/MS spectra of bovine RNase B after treatment using the PNGase F-GST 450 
reactor prepared by non-oriented (a) and oriented (b) immobilization. Protein concentration: 451 
2.5 mg/mL, deglycosylation time: 30 sec. 452 
 453 
Figure 5. MALDI/MS spectra of bovine fetuin: before (a) and after treatment using the 454 
PNGase F-GST reactor prepared by non-oriented (b) and oriented (c) immobilization. Protein 455 
concentration: 1.0 mg/mL, deglycosylation time: 1 min. 456 
 457 
Figure 6. MALDI/MS spectrum of permethylated glycans released from bovine fetuin in the 458 
PNGase F-GST reactor prepared by oriented immobilization. Protein concentration: 1.0 459 
mg/mL, deglycosylation time: 1 min. The individual detected glycans are listed in Table 2. 460 
 461 
Figure 7. Capillary electrophoresis profile of the APTS-labeled glycans released from human 462 
IgG using the PNGase F-GST reactor prepared by oriented immobilization. Protein 463 
concentration: 2.5 mg/mL, deglycosylation time: 3 min. The individual detected glycans are 464 
listed in Table 3. 465 
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Table 1. Glycans released from bovine RNase B. 1 
Peak No. Structure GUCE value [M+Na]
+ 
1 
 
6.76 1257.56 
2 
 
7.62 1419.57 
3 
 
8.35; 8.54; 
8.67 
1581.68 
4 
 
9.03; 9.18; 
9.54 
1743.74 
5 
 
10.13 1905.79 
 2 
Table 1
  
Table 2. Glycans released from bovine fetuin. 1 
Peak No. Structure [M+Na]
+ 
1 
 
2430.88 
2 
 
2791.98 
3 
 
3241.11 
4 
 
3602.22 
5 
 
3963.32 
 2 
Table 2
  
Table 3. Glycans released from human IgG. 1 
Peak No. Structure GUCE value 
1 
 
4.83 
2 
 
4.92 
3 
 
5.91 
4 
 
6.11 
5 
 
7.69 
6 
 
8.20 
7 
 
8.75 
8 
 
9.08 
Table 3
  
9 
 
9.12 
10 
 
10.12 
11 
 
10.47 
 2 
